Bath & Body Works Stock Pops After Beat-And-Raise Quarter
Bath & Body Works stock is higher Monday after the retailer reported better-than-expected results and raised its full-year forecast.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered daily
Kiplinger Today
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more delivered daily. Smart money moves start here.
Sent five days a week
Kiplinger A Step Ahead
Get practical help to make better financial decisions in your everyday life, from spending to savings on top deals.
Delivered daily
Kiplinger Closing Bell
Get today's biggest financial and investing headlines delivered to your inbox every day the U.S. stock market is open.
Sent twice a week
Kiplinger Adviser Intel
Financial pros across the country share best practices and fresh tactics to preserve and grow your wealth.
Delivered weekly
Kiplinger Tax Tips
Trim your federal and state tax bills with practical tax-planning and tax-cutting strategies.
Sent twice a week
Kiplinger Retirement Tips
Your twice-a-week guide to planning and enjoying a financially secure and richly rewarding retirement
Sent bimonthly.
Kiplinger Adviser Angle
Insights for advisers, wealth managers and other financial professionals.
Sent twice a week
Kiplinger Investing Weekly
Your twice-a-week roundup of promising stocks, funds, companies and industries you should consider, ones you should avoid, and why.
Sent weekly for six weeks
Kiplinger Invest for Retirement
Your step-by-step six-part series on how to invest for retirement, from devising a successful strategy to exactly which investments to choose.
Bath & Body Works (BBWI) stock is trading notably higher Monday after the specialty retailer beat top- and bottom-line expectations for its fiscal third quarter and raised its full-year outlook.
In its quarter ended November 2, Bath & Body Works said its revenue increased 3% year over year to $1.6 billion. Its earnings per share (EPS) decreased 5.8% from the year-ago period to 49 cents.
"Our strong results exceeded the high end of our net sales and earnings per diluted share guidance," said Bath & Body Works CEO Gina Boswell in a statement. "As a result, we are raising our full-year guidance to fully reflect this outperformance."
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results topped analysts' expectations. Wall Street was anticipating revenue of $1.58 billion and earnings of 47 cents per share, according to CNBC.
As its CEO mentioned, Bath & Body Works increased its full-year outlook following the strong quarter. The company now expects to revenue to decline between 2.5% and 1.7% and earnings per share to arrive between $3.15 to $3.28. The retailer had previously said it expected revenue to be down between 4% and 2% and earnings per share of $3.06 to $3.26.
"Innovation across our core products, adjacencies, and collaborations is resonating with both new and existing customers supported by the investments we have made in marketing and technology," Boswell said. "As we enter the critical holiday period, I am pleased with our strong execution and the momentum we are building, as we drive towards sustainable, long-term profitable growth."
Is Bath & Body Works stock a buy, sell or hold?
It's been a rough year on the price charts for Bath & Body Works, which was down more than 27% heading into Monday's session. Still, most of Wall Street has kept the faith on the consumer discretionary stock.
According to S&P Global Market Intelligence, the average analyst target price for BBWI stock is $42.76, representing implied upside of nearly 20% to current levels. Additionally, the consensus recommendation is a Buy.
Financial services firm UBS Global Research is taking a more cautious approach to the mid-cap stock, though, as evidenced by its a Neutral rating (equivalent to a Hold) and $38 price target.
"Our view is a soft category demand should weigh on BBWI's fiscal 2024 sales and earnings and limit the stock from outperforming," wrote UBS Global Research analyst Jay Sole in a November 7 note. "We see little chance of upside earnings surprises or price-to-earnings expansion in the near- to medium-term. Over the long term, we think BBWI could rebound and this is a main reason our rating is not Sell."
Related Content
-
The New Reality for EntertainmentThe Kiplinger Letter The entertainment industry is shifting as movie and TV companies face fierce competition, fight for attention and cope with artificial intelligence.
-
Stocks Sink With Alphabet, Bitcoin: Stock Market TodayA dismal round of jobs data did little to lift sentiment on Thursday.
-
Betting on Super Bowl 2026? New IRS Tax Changes Could Cost YouTaxable Income When Super Bowl LX hype fades, some fans may be surprised to learn that sports betting tax rules have shifted.
-
Stocks Sink With Alphabet, Bitcoin: Stock Market Today
A dismal round of jobs data did little to lift sentiment on Thursday.
-
The 4 Estate Planning Documents Every High-Net-Worth Family Needs (Not Just a Will)The key to successful estate planning for HNW families isn't just drafting these four documents, but ensuring they're current and immediately accessible.
-
Love and Legacy: What Couples Rarely Talk About (But Should)Couples who talk openly about finances, including estate planning, are more likely to head into retirement joyfully. How can you get the conversation going?
-
How to Get the Fair Value for Your Shares When You Are in the Minority Vote on a Sale of Substantially All Corporate AssetsWhen a sale of substantially all corporate assets is approved by majority vote, shareholders on the losing side of the vote should understand their rights.
-
Dow Leads in Mixed Session on Amgen Earnings: Stock Market TodayThe rest of Wall Street struggled as Advanced Micro Devices earnings caused a chip-stock sell-off.
-
How to Add a Pet Trust to Your Estate Plan: Don't Leave Your Best Friend to ChanceAdding a pet trust to your estate plan can ensure your pets are properly looked after when you're no longer able to care for them. This is how to go about it.
-
Want to Avoid Leaving Chaos in Your Wake? Don't Leave Behind an Outdated Estate PlanAn outdated or incomplete estate plan could cause confusion for those handling your affairs at a difficult time. This guide highlights what to update and when.
-
I'm a Financial Adviser: This Is Why I Became an Advocate for Fee-Only Financial AdviceCan financial advisers who earn commissions on product sales give clients the best advice? For one professional, changing track was the clear choice.
